Bellevue Healthcare (LON:BBH) Trading Down 0.9% - Should You Sell?

Key Points

• Bellevue Healthcare's stock price decreased by 0.9%, trading at GBX 115.60 ($1.58) with a significantly lower trading volume of 890,112 shares.
• The company reported a negative P/E ratio of -440.88, a negative return on equity of 4.48%, but a >strong>net margin of 169.10%.
• Bellevue Healthcare Trust aims to pay a total dividend of 3.5 pence per ordinary share, mainly from capital, with the same percentage targeted for future financial years.

Bellevue Healthcare (LON:BBH - Get Free Report)'s stock price dropped 0.9% during mid-day trading on Tuesday . The stock traded as low as GBX 115.40 ($1.55) and last traded at GBX 115.60 ($1.56). Approximately 890,112 shares traded hands during trading, a decline of 58% from the average daily volume of 2,102,039 shares. The stock had previously closed at GBX 116.60 ($1.57).

Bellevue Healthcare Price Performance

The firm has a 50-day moving average of GBX 115.65 and a 200-day moving average of GBX 119.01. The stock has a market cap of £154.47 million and a PE ratio of -449.28.

Bellevue Healthcare (LON:BBH - Get Free Report) last announced its quarterly earnings results on Thursday, August 7th. The company reported GBX 0.19 EPS for the quarter. Bellevue Healthcare had a negative return on equity of 4.48% and a net margin of 169.10%.

About Bellevue Healthcare

Bellevue Healthcare Trust plc is a high conviction, long-only investment trust invested in listed or quoted global healthcare equities. It is unconstrained and able to invest regardless of market cap, sub sector or region, and the portfolio is concentrated with a maximum of 35 holdings. The target total dividend in the first financial period is 3.5 pence per ordinary share (to be paid mostly out of capital) and in subsequent financial years will be set at 3.5 per cent.